ArticleInternational urogynecology journal2025
Gynecologic Oncology Patients have Urobiomes that are Similar to Women Without Gynecologic Cancer.
Article in International urogynecology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
introduction and hypothesisTo compare the bladder microbiomes of participants with and without a gynecological cancer at the time of diagnostic surgery to determine their suitability as control participants in urobiome research studies.
methodsIRB-approved clinical sample of continent adult female patients undergoing surgery for suspected gynecologic malignancy. Participants contributed clinical data (abstracted from the electronic medical record), and a catheterized urine sample obtained prior to antibiotic administration on the day of surgery. The study urine sample underwent DNA sequencing following amplification of hyper-variable region 4 (V4) of the bacterial 16S rRNA gene. The sequences were processed, annotated, and decontaminated. Alpha (within-sample) and beta (between-sample) diversity indices were computed, and the microbiome compositions across all participants were compared.
resultsNinety-two women participated, including 20 with a gynecological cancer diagnosis and a comparison group of 72 without gynecologic cancer detected. The mean age was 53 years old (range 22-92) with a mean BMI of 31 kg/m
conclusionsParticipants with a gynecological cancer diagnosis can be used as controls for bladder microbiome studies.
Indexed as
Identifiers
40728720What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.